1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 03 NOVEMBER 2014

Cancer Drug News 03 NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Jakavi's Myelofibrosis Monopoly Set To End
Industry Brief - DARA Appeals FDA To Amend Tamoxifen Citrate/Soltamox Label
Industry Brief - Synta Initiates Phase II I-SPY 2 TRIAL Of Ganetespib In BC
Industry Brief - Lannett Gains US Letrozole Approval
Industry Brief - Curis Granted US Patent Allowance Covering HDAC/PI3K-Targeted Compounds
Industry Brief - Kiadis' ATIR Gains ODD In Europe For AML
Industry Brief - Betta Invests USD20mn In Xcovery To Gain Chinese Rights To X-396
Industry Brief - Dosing Begins In Heat Biologics' Phase II Bladder Cancer Trial Of Vesigenurtacel-L
Industry Brief - Xtandi Phase III Trial Initiated In Hormone-Sensitive Non-Metastatic PCA
Industry Brief - Positive Data From Apogenix' APG101 Phase II GBM Trial
Industry Trend Analysis - BMS Fortifies Immuno-Oncology Pipeline With Acquisition Option
Industry Trend Analysis - Next-Generation Antibodies Instigate New Wave Of Collaborations
Industry Brief - 4SC Strengthens Resminostat Patent Protection
Industry Trend Analysis - Ventana Secures Further Companion Diagnostic Partnership
Industry Brief - RaQualia Granted Japanese Patent Allowance For EP4 Antagonist
Industry Brief - Genmab Transfers Ofatumumab Collaboration From GSK To Novartis
Industry Brief - QIAGEN/Astellas Team Up For Developing Companion Diagnostics
Industry Trend Analysis - Oncology Will Be A Major Growth Driver For Amgen
Industry Brief - Celator Raises Funds In Public Share Offering
Industry Brief - Cancer Conferences - February 2015

Table Of Contents

Cancer Drug News 03 NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.